Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Deterding

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
The Lancet. Infectious Diseases|December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 studyKatja Deterding, Christoph D Spinner, Eckart Schott, et al.
Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trialKatja Dinkelborg, Julia Kahlhöfer, Petra Dörge, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Telomerase gene mutations are associated with cirrhosis formationDaniel Hartmann, Ujala Srivastava, Michaela Thaler, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
The Lancet. Infectious Diseases|December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 studyKatja Deterding, Christoph D Spinner, Eckart Schott, et al.
Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trialKatja Dinkelborg, Julia Kahlhöfer, Petra Dörge, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Telomerase gene mutations are associated with cirrhosis formationDaniel Hartmann, Ujala Srivastava, Michaela Thaler, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Pageof 10